Study of a new continuous glucose monitor for adults with diabetes
Part of Hormones & metabolism clinical trials.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have type 1 or type 2 diabetes, and your treatment must have been stable for the last 3 months.
- Your most recent A1C (a measure of blood sugar control over 3 months) must be above 7.5%.
- You have not used a real-time CGM (a device that shows glucose continuously) in the last 3 months.
- You must not have had severe low blood sugar (needing help from someone else) in the last year, or a seizure or loss of consciousness from low sugar in the last 3 years.
- You must not have had a heart attack or stroke in the last 6 months, and your kidney function must be okay (eGFR of 30 or higher).
- You cannot be pregnant, planning pregnancy, or breastfeeding during the study.
- You must be willing to wear the sensor and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.